S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Obama’s 2024 Confession (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Obama’s 2024 Confession (Ad)
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Airbnb stock bulls just went all in before earnings
Obama’s 2024 Confession (Ad)
3 stocks set to benefit from record Valentine's Day spending
Recession risks are fading, business economists say, but political tensions pose threat to economy
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Obama’s 2024 Confession (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Obama’s 2024 Confession (Ad)
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Airbnb stock bulls just went all in before earnings
Obama’s 2024 Confession (Ad)
3 stocks set to benefit from record Valentine's Day spending
Recession risks are fading, business economists say, but political tensions pose threat to economy
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Obama’s 2024 Confession (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Obama’s 2024 Confession (Ad)
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Airbnb stock bulls just went all in before earnings
Obama’s 2024 Confession (Ad)
3 stocks set to benefit from record Valentine's Day spending
Recession risks are fading, business economists say, but political tensions pose threat to economy
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Obama’s 2024 Confession (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Obama’s 2024 Confession (Ad)
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Airbnb stock bulls just went all in before earnings
Obama’s 2024 Confession (Ad)
3 stocks set to benefit from record Valentine's Day spending
Recession risks are fading, business economists say, but political tensions pose threat to economy

Cardinal Health (CAH) Stock Forecast & Price Target

$104.95
+2.22 (+2.16%)
(As of 02/9/2024 08:56 PM ET)

Cardinal Health Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 11 Analyst Ratings

Analysts' Consensus Price Target

$101.38
-3.40% Downside
High Forecast$125.00
Average Forecast$101.38
Low Forecast$90.00
TypeCurrent Forecast
2/12/23 to 2/12/24
1 Month Ago
1/13/23 to 1/13/24
3 Months Ago
11/14/22 to 11/14/23
1 Year Ago
2/12/22 to 2/12/23
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
4 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
Hold
5 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
7 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$101.38$99.23$95.92$80.64
Predicted Upside-3.40% Downside9.21% Upside10.74% Upside10.17% Upside
Get Cardinal Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter.

CAH Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CAH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cardinal Health Stock vs. The Competition

TypeCardinal HealthMedical CompaniesS&P 500
Consensus Rating Score
2.36
2.68
2.48
Consensus RatingHoldModerate BuyHold
Predicted Upside-3.40% Downside877.34% Upside8.84% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/9/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
2/5/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$122.00 ➝ $125.00+21.17%
1/3/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$117.00+14.01%
12/14/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageUnderweight$96.00-11.15%
11/17/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$101.00 ➝ $112.00+8.24%
10/11/2023Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$100.00 ➝ $95.00+3.69%
8/16/2023TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform ➝ Market Perform$88.00 ➝ $90.00-0.56%
8/16/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$92.00 ➝ $100.00+10.46%
8/16/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$107.00 ➝ $108.00+19.30%
8/16/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$94.00 ➝ $96.00+6.04%
7/17/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$91.00 ➝ $99.00+6.29%
6/12/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$90.00 ➝ $100.00+15.82%
6/12/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$88.00 ➝ $90.00+4.24%
5/8/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$88.00 ➝ $90.00+8.59%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 07:51 AM ET.












CAH Price Target - Frequently Asked Questions

What is Cardinal Health's consensus rating and price target?

According to the issued ratings of 11 analysts in the last year, the consensus rating for Cardinal Health stock is Hold based on the current 1 sell rating, 5 hold ratings and 5 buy ratings for CAH. The average twelve-month price prediction for Cardinal Health is $101.38 with a high price target of $125.00 and a low price target of $90.00. Learn more on CAH's analyst rating history.

Do Wall Street analysts like Cardinal Health more than its competitors?

Analysts like Cardinal Health less than other Medical companies. The consensus rating for Cardinal Health is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how CAH compares to other companies.

Is Cardinal Health being upgraded by Wall Street analysts?

Over the previous 90 days, Cardinal Health's stock had 1 upgrade by analysts.

Does Cardinal Health's stock price have much upside?

According to analysts, Cardinal Health's stock has a predicted upside of 8.62% based on their 12-month stock forecasts.

What analysts cover Cardinal Health?

Cardinal Health has been rated by Argus, Barclays, JPMorgan Chase & Co., UBS Group, and Wells Fargo & Company in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:CAH) was last updated on 2/12/2024 by MarketBeat.com Staff

From Our Partners

My Account -